MK-0000-215
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-0000-215, covering 2013-10-28 to 2013-10-28. Get the full timeline:
Most recent: Clinical Trial Update: Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215) [Phase 1]